Investors are on edge as the S&P 500 dropped below its 50-day moving average for the first time since the tariff tantrum back in April. But if you've been actively trading these markets, you've likely noticed trouble brewing for a few weeks as speculative assets like AI stocks and Bitcoin have plummeted while gold and safer sectors soar.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Primo Brands To Contact Him Directly To Discuss Their Options

T. Rowe Price has launched four new active fixed income ETFs, with three of those being tax-free municipal bond ETFs. Tax-free muni bond ETFs have seen increased interest in recent years, taking advantage of the ETF wrapper's strengths and flexibility compared to mutual funds.

LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 12, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”).

A securities fraud lawsuit has been filed against CarMax Inc. (KMX). Investors who have lost money should contact Block & Leviton LLP by January 2, 2026.

Altimmune, Inc. ( ALT ) Jefferies London Healthcare Conference 2025 November 20, 2025 3:00 AM EST Company Participants Vipin Garg - President, CEO & Director Christophe Arbet-Engels - Chief Medical Officer Conference Call Participants Jiale Song - Jefferies LLC, Research Division Presentation Jiale Song Jefferies LLC, Research Division All right. Good morning, everyone, to Jefferies' London Healthcare Conference 2025.

Cracker Barrel shareholders spared CEO Julie Felss Masino after a branding crisis that wiped out hundreds of millions of dollars in value.

Applied Digital Corporation (NASDAQ: APLD) shares are trading lower on Thursday. Some analysts believe the reversal in NVIDIA Corporation (NASDAQ: NVDA) after its strong earnings report is the reason for the move.

Company Announcement COPENHAGEN, Denmark; November 20, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided to grant 6,933 restricted stock units and 7,377 warrants to employees of the Company and the Company's subsidiaries. Each restricted stock unit is awarded cost-free and provides the owner with a conditional right to receive one share in Genmab A/S of nominally DKK 1.

Shopify's subscription revenues jump again as Plus expands and high-margin recurring income cements a steadier long-term growth base.

Nvidia's (NVDA) earnings posted record numbers for the company and bolstered a market-wide rally early in Thursday's session. That rally faded by the afternoon when the stock fell 6% from its intraday high.

NEW YORK--(BUSINESS WIRE)--The Board of Directors of Marsh McLennan (NYSE: MMC) today authorized the renewal of the Company's share repurchase program, allowing management to buy back up to $6 billion of the Company's common stock going forward, which supersedes any prior authorization. About Marsh McLennan Marsh McLennan (NYSE: MMC) is a global leader in risk, strategy and people, advising clients in 130 countries across four businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman. With annu.

NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pilot Wave Holdings Management, LLC ("Pilot Wave") today announced the sale of its portfolio company, Connect Atlantic Utility Services ("CAUS" or "Connect Atlantic"), to Centuri Holdings, Inc. ("Centuri"), a leading North American utility-infrastructure services provider. Pilot Wave acquired Connect Atlantic with the goal of strengthening operations, accelerating growth, and positioning the business for long-term scale in electric transmission, distribution, and storm-restoration markets across Atlantic Canada and into the United States.

NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Graviton Bioscience Corporation, a clinical-stage biotechnology company developing selective ROCK2 inhibitors for metabolic, inflammatory, fibrotic, and central nervous system disorders, among other therapeutic indications, today announced that Samuel Waksal, Ph.D., Chief Executive Officer, will participate in a fireside chat at the 8th Annual Evercore HealthCONx Conference.

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (NYSE:VIRT), a leading provider of global, multi-asset financial services that delivers liquidity and innovative, transparent products across the complete investment cycle to the global markets, is proud to announce that Virtu Financial received recognition in seven categories at the 2025 TRADE Awards in New York and London. Virtu Financial was honored in London with TCA Provider of the Year and Best Dark Pool Capabilities, and in New York with Best Customer Support & Consulting.

Jim Stewart, NYT columnist, joins 'The Exchange' to discuss the bidding happening for Warner Bros. Discovery, if bidders will end up overpaying and much more.

Ayako Yoshioka, portfolio consulting director at Wealth Enhancement Group, says AI-related valuations are reasonable. She discusses how Nvidia's earnings are being digested by investors with Caroline Hyde and Ed Ludlow on “Bloomberg Tech.

LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 29, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR AVANTOR INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.

LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”).

CNBC's Deirdre Bosa reports on news regarding Alphabet.